Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature

American Heart Journal

Volumn 164, Issue 2, 2012, Pages

  Berger, Jeffrey S ^a   Sallum, Rachel H ^b   Katona, Brian ^c   Maya, Juan ^c   Ranganathan, Gayatri ^b   Xu, Yingxin ^b   Mwamburi, Mkaya ^b,d  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c ASTRAZENECA   (United Kingdom)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTICLE; BLEEDING; CORONARY STENT; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; HEART DISEASE; HEART INFARCTION; HUMAN; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; META ANALYSIS (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 84864724485     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.04.001     Document Type: Review

References (18)

1. S. Tickoo, M.T. Roe, and E.D. Peterson Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative Am J Cardiol 99 2007 1496 1499 (Pubitemid 46770631)
2. S.R. Mehta, J.P. Bassand, and S. Chrolavicius Dose comparisons of clopidogrel and aspirin in acute coronary syndromes N Engl J Med 363 2010 930 942
3. S.S. Jolly, J. Pogue, and K. Haladyn Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study Eur Heart J 30 2009 900 907
4. R.S. Wright, J.L. Anderson, and C.D. Adams 011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 2022 2060
5. H.M. Krumholz, J.L. Anderson, and B.L. Bachelder ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine Circulation 118 2008 2596 2648
6. J.P. Bassand, C.W. Hamm, and D. Ardissino Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
7. F. Van de Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
8. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
9. R.A. Harrington, R.C. Becker, and C.P. Cannon Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 670S 707S (Pubitemid 351892975)
10. D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 2009 e1000097
11. Oxford Centre for Evidence-Based Medicine Levels of evidence 2009 [cited March 2010] http://www.cebm.net/index.aspx?o=1025
12. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12 (Pubitemid 26120810)
13. L. Hedges I. O. Statistical methods for meta-analysis 1985 Academic Press Orlando, FL
14. J.P. Higgins, S.G. Thompson, and J.J. Deeks Measuring inconsistency in meta-analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
15. R.J. Peters, S.R. Mehta, and K.A. Fox Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study Circulation 108 2003 1682 1687 (Pubitemid 37243654)
16. S.R. Mehta, J.F. Tanguay, and J.W. Eikelboom Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
17. J.S. Berger, A. Stebbins, and C.B. Granger Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy Circulation 117 2008 192 199
18. C. Patrono, C. Baigent, and J. Hirsh Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 199S 233S (Pubitemid 351894914)